Males | |||
 | Metabolically healthy | Metabolically unhealthy | p value |
 | HOMA-IR Median (interquartile range) |  | |
NCEP-0 | 1.32 (0.89–1.64) | 2.12 (1.49–2.71) | <0.001 |
NCEP-1 | 1.48 (1.08–1.95) | 2.31 (1.90–3.01) | <0.001 |
NCEP-2 | 1.61 (1.13–2.19) | 2.89 (2.19–3.45) | <0.001 |
Doumatey et al. | 1.52 (1.07–1.95) | 2.35 (1.95–3.02) | <0.001 |
Hamer et al. | 1.51 (1.07–1.95) | 2.28 (1.65–2.96) | <0.001 |
Aguilar-Salinas et al. | 1.53 (1.08–1.97) | 2.51 (1.96–3.08) | <0.001 |
Karelis et al. | 1.27 (0.84–1.65) | 2.13 (1.53–2.73) | <0.001 |
Lavie et al. | 1.29 (0.83–1.66) | 2.13 (1.57–2.80) | <0.001 |
Females | |||
 | HOMA-IR Median (interquartile range) |  | |
NCEP-0 | 1.24 (0.78–1.79) | 1.71 (1.09–2.27) | <0.001 |
NCEP-1 | 1.31 (0.89–1.84) | 2.13 (1.51–2.77) | <0.001 |
NCEP-2 | 1.45 (0.95–1.96) | 2.72 (2.18–3.19) | <0.001 |
Doumatey et al. | 1.52 (0.98–2.07) | 1.73 (1.02–2.47) | 0.115 |
Hamer et al. | 1.36 (0.91–1.85) | 1.96 (1.30–2.54) | <0.001 |
Aguilar-Salinas et al. | 1.51 (0.96–2.05) | 1.88 (1.11–2.66) | 0.039 |
Karelis et al. | 1.28 (0.82–1.71) | 1.97 (1.27–2.55) | <0.001 |
Lavie et al. | 1.29 (0.89–1.82) | 1.83 (1.20–2.42) | <0.001 |